[HTML][HTML] The mechanism of action of N-acetylcysteine (NAC): The emerging role of H2S and sulfane sulfur species

B Pedre, U Barayeu, D Ezeriņa, TP Dick - Pharmacology & therapeutics, 2021 - Elsevier
Initially adopted as a mucolytic about 60 years ago, the cysteine prodrug N-acetylcysteine
(NAC) is the standard of care to treat paracetamol intoxication, and is included on the World …

[HTML][HTML] Phages for biofilm removal

C Ferriol-González, P Domingo-Calap - Antibiotics, 2020 - mdpi.com
Biofilms are clusters of bacteria that live in association with surfaces. Their main
characteristic is that the bacteria inside the biofilms are attached to other bacterial cells and …

[HTML][HTML] N-acetylcysteine: a review of clinical usefulness (an old drug with new tricks)

GK Schwalfenberg - Journal of nutrition and metabolism, 2021 - hindawi.com
Objective. To review the clinical usefulness of N-acetylcysteine (NAC) as treatment or
adjunctive therapy in a number of medical conditions. Use in Tylenol overdose, cystic …

[HTML][HTML] The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress

G Raghu, M Berk, PA Campochiaro… - Current …, 2021 - ncbi.nlm.nih.gov
Oxidative stress, which results in the damage of diverse biological molecules, is a ubiquitous
cellular process implicated in the etiology of many illnesses. The sulfhydryl-containing …

[HTML][HTML] Biological activities and potential oral applications of N-acetylcysteine: progress and prospects

Y Pei, H Liu, Y Yang, Y Yang, Y Jiao, FR Tay… - … medicine and cellular …, 2018 - hindawi.com
N-Acetylcysteine (NAC), a cysteine prodrug and glutathione (GSH) precursor, has been
used for several decades in clinical therapeutic practices as a mucolytic agent and for the …

N-acetylcysteine as adjuvant therapy for COVID-19–a perspective on the current state of the evidence

KK Wong, SWH Lee, KP Kua - Journal of inflammation research, 2021 - Taylor & Francis
The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with …

The role of nanotechnology in combating biofilm-based antibiotic resistance

B Malaekeh-Nikouei, BSF Bazzaz, E Mirhadi… - Journal of Drug Delivery …, 2020 - Elsevier
Many serious infections result from persistent microbial biofilms that do not respond to
conventional antibiotic therapy. Various therapeutic approaches have been developed and …

Mucoadhesive, antibacterial, and reductive nanogels as a mucolytic agent for efficient nebulized therapy to combat allergic asthma

D Zhao, D Li, X Cheng, Z Zou, X Chen, C He - ACS nano, 2022 - ACS Publications
Asthma is an intractable disease involving the infiltration of inflammatory cells and mucus
plugging. Despite small molecular mucolytics having the ability to break the disulfide bonds …

Chronic tonsillitis and biofilms: a brief overview of treatment modalities

M Abu Bakar, J McKimm, SZ Haque… - Journal of …, 2018 - Taylor & Francis
Recurrent tonsillitis is described as when an individual suffers from several attacks of
tonsillitis per year. Chronic and recurrent tonsillitis both cause repeated occurrences of …

[HTML][HTML] N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions

EP Amaral, EL Conceição, DL Costa, MS Rocha… - BMC microbiology, 2016 - Springer
Background Mycobacterium tuberculosis infection is thought to induce oxidative stress. N-
acetyl-cysteine (NAC) is widely used in patients with chronic pulmonary diseases including …